Clinical Trials Browser

Phase 1/2 × Advanced Liver Cancer × Bevacizumab × Clear all

NCT05603039 2022-11-02

A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma

Phase 1/2 Unknown

Advanced Liver Cancer